(Q36753818)

16 August 2017

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients (English)

1 reference

16 August 2017

0 references

1 reference

C V Fletcher

1

1 reference

16 August 2017

J A Englund

2

1 reference

16 August 2017

C K Edelman

3

1 reference

16 August 2017

C R Gross

4

1 reference

16 August 2017

D L Dunn

5

1 reference

16 August 2017

H H Balfour

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 1991

1 reference

Antimicrobial Agents and Chemotherapy

16 August 2017

1 reference

16 August 2017

35

1 reference

16 August 2017

5

1 reference

16 August 2017

938-943

1 reference

Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Clinical pharmacokinetics of acyclovir

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Fever in renal transplant recipients: Causes, prognostic significance and changing patterns at the University of Minnesota Hospital

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Acyclovir-induced renal failure. Clinical course and histology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Drugs five years later: acyclovir

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Some suggestions for measuring predictive performance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

A program package for simulation and parameter estimation in pharmacokinetic systems

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245132

INFECTIOUS PULMONARY DISEASE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY FOR ORGAN TRANSPLANTATION

5 September 2018

1 reference

12 December 2020

A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]

1 reference

12 December 2020

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

12 December 2020

Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution

1 reference

12 December 2020

Renal transplantation at the University of Minnesota during the 1980s

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.35.5.938

1 reference

16 August 2017

1 reference

16 August 2017

1 reference